Integer Holdings EBITDA Margin 2010-2022 | ITGR

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Integer Holdings (ITGR) over the last 10 years. The current EBITDA margin for Integer Holdings as of March 31, 2022 is .
Integer Holdings EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2022-03-31 $1.24B $0.21B 17.23%
2021-12-31 $1.22B $0.22B 18.35%
2021-09-30 $1.18B $0.22B 19.03%
2021-06-30 $1.11B $0.23B 20.60%
2021-03-31 $1.04B $0.20B 19.03%
2020-12-31 $1.07B $0.21B 19.20%
2020-09-30 $1.13B $0.20B 17.88%
2020-06-30 $1.20B $0.21B 17.36%
2020-03-31 $1.27B $0.25B 19.50%
2019-12-31 $1.26B $0.24B 19.38%
2019-09-30 $1.24B $0.26B 21.04%
2019-06-30 $1.24B $0.30B 23.93%
2019-03-31 $1.24B $0.30B 23.85%
2018-12-31 $1.21B $0.29B 24.14%
2018-09-30 $1.14B $0.29B 25.37%
2018-06-30 $1.12B $0.25B 22.31%
2018-03-31 $1.08B $0.24B 22.53%
2017-12-31 $1.14B $0.24B 21.13%
2017-09-30 $0.96B $0.22B 23.33%
2017-06-30 $1.02B $0.22B 21.65%
2017-03-31 $1.09B $0.21B 19.39%
2016-12-31 $1.08B $0.19B 17.77%
2016-09-30 $1.35B $0.16B 12.12%
2016-06-30 $1.15B $0.12B 10.22%
2016-03-31 $0.97B $0.09B 8.74%
2015-12-31 $0.80B $0.07B 8.61%
2015-09-30 $0.65B $0.08B 12.71%
2015-06-30 $0.68B $0.09B 13.86%
2015-03-31 $0.68B $0.10B 14.96%
2014-12-31 $0.69B $0.11B 16.57%
2014-09-30 $0.70B $0.11B 15.68%
2014-06-30 $0.69B $0.11B 15.77%
2014-03-31 $0.69B $0.11B 15.36%
2013-12-31 $0.66B $0.10B 15.51%
2013-09-30 $0.65B $0.10B 15.17%
2013-06-30 $0.64B $0.09B 13.93%
2013-03-31 $0.64B $0.09B 13.86%
2012-12-31 $0.65B $0.08B 13.00%
2012-09-30 $0.63B $0.09B 14.63%
2012-06-30 $0.60B $0.10B 16.67%
2012-03-31 $0.58B $0.11B 18.10%
2011-12-31 $0.57B $0.11B 19.30%
2011-09-30 $0.56B $0.12B 21.57%
2011-06-30 $0.56B $0.12B 21.76%
2011-03-31 $0.55B $0.12B 21.82%
2010-12-31 $0.53B $0.12B 21.76%
2010-09-30 $0.53B $0.09B 17.11%
2010-06-30 $0.52B $0.05B 10.19%
2010-03-31 $0.51B $0.05B 9.34%
2009-12-31 $0.52B $0.05B 9.20%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $2.397B $1.221B
Integer Holdings Corporation manufactures and develops medical devices and components primarily for original equipment manufacturers, which depend on it to design, develop and produce intellectual property protected medical device technologies. Integer Holdings operates through two segments: Medical Sales and Non-Medical Sales. Medical Sales has three sub-segments Advanced Surgical, Orthopedics and Portable Medical; Cardio and Vascular; and Cardiac Rhythm Management & Neuromodulation.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $213.272B 21.66
Edwards Lifesciences (EW) United States $60.297B 42.35
Alcon (ALC) Switzerland $34.105B 29.74
STERIS (STE) Ireland $20.806B 26.28
Fresenius Medical Care AG KGaA (FMS) Germany $14.622B 13.13
Teleflex (TFX) United States $12.103B 19.34
Globus Medical (GMED) United States $5.886B 29.36
Penumbra (PEN) United States $4.964B 313.69
Glaukos (GKOS) United States $2.237B 0.00
Nevro (NVRO) United States $1.735B 0.00
Paragon 28 (FNA) United States $1.271B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.258B 22.52
Artivion (AORT) United States $0.780B 84.30